US Stocks
/
Pelthos Therapeutics Inc. Share Price

Pelthos Therapeutics Inc. Share Price

AMEX: PTHS | Micro Cap
$20.85
-$0.18 (-0.86%) Last updated on 09 Oct, 2026 | 21:22 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Pelthos Therapeutics Inc. Stock Performance

Open
$20.77
Prev. Close
$21.03
Circuit Range
N/A
Day Range
$20.77 - $20.77
Year Range
$19.56 - $37.24
Volume
139
Average Traded
$20.77

Pelthos Therapeutics Inc. Share Price Today

As of 9 October 2026, Pelthos Therapeutics Inc.'s share price is $20.85. The stock opened at $20.77, compared to its previous close of $21.03. During today's trading session, Pelthos Therapeutics Inc.'s share price traded between $20.77 and $20.77, with an average price of $20.77. Over the past 52 weeks, the stock has recorded a high of $37.24 and a low of $19.56. In terms of performance, Pelthos Therapeutics Inc.'s share price has declined by 16.33% over the last six months and is down 36.82% on a year-on-year basis.

Pelthos Therapeutics Inc. Share Price Chart

$20.77$20.77
L
Show Current Price
H

Pelthos Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$39.21M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-22.57
Revenue (TTM)
$16.80B
Return On Equity (TTM)
5755.63%
Profit Margin
-257.86%
Debt to Equity
-46.58
Quarterly Earnings Growth YoY
-44.21%

Pelthos Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$7.41$9.39$10.91$15.60
Net Profit-$16.24-$21.66-$25.07-$23.42
Net Profit Margin-219.16%-230.67%-229.79%-150.13%
Income ChangeN/A-33.37%-15.74%6.58%

Pelthos Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$16.80
Net Profit-$43.32
Net Profit Margin-257.86%
Income ChangeN/A

About Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens. The Company currently has three U.S. Food and Drug Administration (FDA) approved products in its commercial portfolio, in various stages of commercialization, including ZELSUVMITM, XEPI, and XEGLYZE. The company operates in two reporting segments: the sale, promotion, and commercialization of approved commercial products, the Commercial Operations segment, and research and development activities related to developing a novel and proprietary class of NaV blockers that target the body's peripheral nervous system; and supportive activities to expand the NITRICIL nitric oxide-based technology.

Pelthos Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$21.13
$20.77
-4.24%
Sep 2026
$24.56
$21.68
-19.27%
Aug 2026
$27.97
$26.86
-6.41%
Jul 2026
$28.26
$28.70
+2.34%
Jun 2026
$26.29
$28.05
+7.49%
May 2026
$25.22
$26.09
+4.70%
Apr 2026
$22.27
$24.92
+18.61%
Mar 2026
$24.58
$21.01
-11.89%
Feb 2026
$23.97
$23.84
-4.39%
Jan 2026
$27.96
$24.94
-15.60%
Dec 2025
$27.86
$29.55
+4.79%
Nov 2025
$32.99
$28.20
-14.55%

PTHS Share Price FAQs

What is Pelthos Therapeutics Inc. share price today?

chevron-up
Pelthos Therapeutics Inc. share price today is $20.85 as on October 9, 2026 at 9:22 pm IST.

What is the 52 week high and 52 week low of Pelthos Therapeutics Inc. stock?

chevron-up
The 52 week high of Pelthos Therapeutics Inc. stock is $37.24, while the 52 week low is $19.56 as of 9 Oct '26.

What is PTHS's market capitalisation today?

chevron-up
PTHS market capitalisation is $39.21M as of October 9, 2026, at 10:17 pm IST.

What is PTHS's net income for the last quarter?

chevron-up
PTHS's net income for the last quarter is -23.42B USD.

What is the 5 year returns of PTHS?

chevron-up
The 5 year returns of PTHS is -44.69% as on 9 Oct '26.

What is the high & low stock price of PTHS today?

chevron-up
PTHS stock price hit a high of $20.77 and low of $20.77 as of 9 Oct '26.

Can I buy PTHS shares in India?

chevron-up
Yes. You can buy PTHS in India by opening an international trading account.